Frank Hu
About Frank Hu
Frank Hu is the Associate Scientific Director at Bristol Myers Squibb, with over 20 years of experience in the pharmaceutical industry.
Company
Frank Hu is currently employed at Bristol Myers Squibb, a global pharmaceutical company known for its focus on innovative medicines. He has accumulated over 20 years of experience with the company, showcasing his long-term commitment and valuable contributions to its mission and goals. His role as an Associate Scientific Director highlights his involvement in leading scientific initiatives within the organization.
Title
Frank Hu holds the title of Associate Scientific Director at Bristol Myers Squibb. This role involves overseeing scientific projects and leading research efforts within the company. His position underscores his advanced expertise and leadership in the field of pharmaceutical science.
Previous Role at Celgene
Frank Hu served as a Senior Principal Scientist at Celgene from 2018 to 2019, a pharmaceutical company recognized for its work in cancer and inflammatory disorders. During his one-year tenure, he was responsible for advancing scientific research projects and contributing to Celgene's innovative therapies.
Education and Expertise
Frank Hu studied at the University of Science and Technology of China (USTC), which laid the foundation for his career in the pharmaceutical industry. His extensive experience in scientific leadership roles at notable pharmaceutical companies like Bristol Myers Squibb and Celgene highlights his expertise in the field.
Professional Background
Frank Hu's professional journey in the pharmaceutical industry began with Bristol Myers Squibb, where he worked as a Principal Scientist from 2000 to 2018. After a brief stint at Celgene as a Senior Principal Scientist, he returned to Bristol Myers Squibb in November 2019 as an Associate Scientific Director. His long-standing career is characterized by significant contributions to scientific research and leadership in pharmaceutical development.